Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-19

Clinical Trial Update: ESBA105 in Patients With Severe Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 study of ESBA105 for severe dry eye disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESBA105

Snippet

Sponsor: Alcon Research | Conditions: Eyes Dry Chronic | Phase 2 | Status: COMPLETED | Results posted: 2013-04-19